Accumulating evidence suggests that vitamin Ds effect on glucose metabolism likely complements semaglutides mechanisms, particularly in enhancing insulin sensitivity and reducing fasting glucose levels
This appetite suppression contributes to weight loss, which varies by dose and individual factorsclinical trials have shown weight reductions typically ranging from 5-15% in people with type 2 diabetes and higher (up to 20% at maximum doses) in people without diabetes over 72 weeks
It was found to be more efficacious than placebo [1.33(1.55, 1.12)]
It represents a next-generation incretin-based compound of significant interest in metabolic disease research, with studied effects on energy homeostasis, insulin secretion, and lipid metabolism in preclinical models
When you take semaglutide, your body begins to tap into fat stores more consistently
Hormone Research in Paediatrics, 95 (3), 178-185